John E. Harris, MD, PhD – Oral Abstract
Survey Investigating the Prevalence of Vitiligo and Vitiligo Signs among Adults in Europe, Japan, and the United States
Entries by Patrick Dockins
Saad Altalhab, MBBS
Risk Factors of Infection Post Non-cultured Melanocyte Keratinocyte Transplantation for Vitiligo
AMIT G. PANDYA, MD
Advances in Treatment of Vitiligo With JAK Inhibitors
Meri K. Tulic, PhD
Analysis of Matched Skin and Gut Microbiome of Vitiligo Patients Reveals Dysbiosis in Lesional Skin: Association with Mitochondrial Damage and Changes in Immune Function
Victor Huang, MD
An Open-Label Pilot Study of Abatacept (CTLA4-Ig) for the Treatment of Nonsegmental Vitiligo
Iltefat H. Hamzavi, MD, FAAD Oral Abstract
Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical Characteristics
Nanja van Geel, MD, PhD
International Collaborative Project to Standardize the Assessment and Monitoring of Vitiligo in Clinical Trials, Registries and Clinical Practice
Julien Seneschal, MD, PHD
Vitiligo: Looking at the Memory T Cell Response
Jesslyn Alyce Magee, MS
Pilot Network Model for Automated Vitiligo Lesion Segmentation: Promise and Challenges
